查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439244

中心静脉导管 - 全球市场考量、竞争格局、市场预测 (2030)

Central Venous Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球中心静脉导管市场规模预计到2023年将达到27.3亿美元，到2030年将达到40.4亿美元，2024-2030年预测期间复合年增长率为6.85%。由于癌症、心血管疾病和肾臟疾病等慢性疾病盛行率的增加、久坐生活方式的增加、输血次数的增加以及产品技术的进步等因素，预计该市场将蓬勃发展，预计将推动收入预测期内（2024-2030）中心静脉导管市场的成长。

中心静脉导管市场动态

中心静脉导管市场的显着驱动因素之一是癌症、心血管疾病和肾臟疾病等慢性疾病的盛行率不断上升。

由于年龄和肥胖等多种因素，心臟衰竭和中风等心血管疾病的盛行率在全球范围内不断增加，市场预计将扩大。例如，根据世界卫生组织 (WHO) (2022) 的数据，心血管疾病 (CVD) 是 2019 年全球主要死亡原因之一。据估计，2019 年约有 1,790 万人死于 CVD，占全球死亡人数的 32%。这表明对降低死亡率的心臟手术的需求不断增加，进一步导致中心静脉导管的使用和需求增加，对市场产生积极影响。

各种类型癌症的盛行率不断增加，其中中心静脉导管主要用于向患者施用化疗和其他药物，预计将对中心静脉导管市场产生积极影响。根据世界卫生组织（WHO）数据显示，2020年，乳腺癌226万例，肺癌221万例，结直肠癌193万例，前列腺癌141万例，胃癌109万例。被报道了。Ta。

此外，由于老化是大多数慢性病的危险因子之一，包括癌症、心血管疾病等，老年患者负担的增加可能会增加慢性病的盛行率。例如，根据世界卫生组织（2022）的数据，到2030年，世界上六分之一的人将年龄在60岁或以上。到2050年，全球60岁以上的人口数量将增加一倍。因此，全球老年人口的增加可能会增加预测期内对中心静脉导管市场的需求。

然而，越来越多的中心静脉导管召回事件以及与中心静脉导管市场相关的传染病可能会限制中心静脉导管市场的成长。

中心静脉导管市场报告称，由于作为遏制 COVID-19 传播的必要措施而实施的封锁，市场成长短期受到限制。COVID-19 大流行导致卫生服务和医疗程序的实施发生重大重组。为了简化COVID-19 危机期间的工作流程，许多国家根据紧急医疗需求将医疗程序分开，将包括心血管和其他手术、化疗等在内的各种医疗程序分开。被认为是选择性的手术已停止，导致手术量下降市场。然而，随着包括医疗行业在内的各行业活动的恢復，中心静脉导管市场在2024-2030年的预测期内呈上升趋势。

中心静脉导管市场区隔分析

在中心静脉导管市场的产品类型部分，预计在预测期内（2024-2030年），隧道式中心静脉导管将在中心静脉导管市场实现显着的收入成长。

这是由于隧道式中心静脉导管具有多种用途和益处。隧道式中心静脉导管的主要优点是用途广泛，几乎适用于 100% 的患者，并且可以插入多个部位。

此外，这些导管更稳定，因为它们通过皮下到达单独的出口点，这使得它们有利于长期静脉通路，例如肠外营养、液体復苏、抗生素、化疗和血液透析。此外，即使放置隧道导管后，患者出院后仍可继续接受静脉治疗数週或数月。

众所周知，隧道式中心静脉导管静脉注射非常安全，并且允许以更简单的方式进行静脉治疗，减少患者的不适并提高其可接受性。

本报告提供了全球中心静脉导管市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章 中心静脉导管市场报告简介

第2章 中心静脉导管市场概要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第3章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章 中心静脉导管市场关键因素分析

  • 中心静脉导管市场驱动因素
    • 慢性病患病率增加
    • 增加老年患者的负担
    • 增加输血
    • 产品技术进步
  • 中心静脉导管市场的控制因素与挑战
    • 中心静脉导管回收数量增加
    • 中心静脉导管相关併发症
  • 中心静脉导管市场机会
    • 全球中心静脉导管研发活动支出增加

第5章 中心静脉导管市场波特五力分析

第6章 COVID-19对中心静脉导管市场的影响分析

第七章 中心静脉导管市场布局

  • 按产品类型
    • 隧道式中心静脉导管
    • 非隧道式中心静脉导管
  • 按设计
    • 手动的
    • 自动的
  • 按地点
    • 颈内静脉
    • 股静脉
    • 锁骨下静脉
  • 按最终用户
    • 医院、诊所
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 中心静脉导管市场：全球公司份额分析- 3至5家主要公司

第9章 中心静脉导管市场公司与产品概况

  • B. Braun Melsungen AG
  • ZOLL Medical Corporation
  • VOGT Medical
  • Insung Medical
  • Cook Group
  • Lepu Medical Technology Co., Ltd.
  • Teleflex Incorporated
  • Poly Medicure Ltd.
  • ICU Medical Inc.
  • Becton, Dickinson and Company
  • Edwards Lifesciences Corporation
  • Vygon
  • Kimal
  • Medline Industries, LP
  • Medical Components, Inc.
  • Medtronic
  • Prunus Medical
  • Merit Medical Systems
  • SCW Medicath Ltd
  • Prodimed

第10章 KOL观点

第11章 专案方法

第12章 关于 DelveInsight

第13章 免责声明与联络我们

Product Code: DIMDCL0031

CENTRAL VENOUS CATHETERS MARKET BY PRODUCT TYPE (TUNNELED CENTRAL VENOUS CATHETERS AND NON-TUNNELED CENTRAL VENOUS CATHETERS), BY DESIGN (SINGLE LUMEN CENTRAL VENOUS CATHETERS, DOUBLE LUMEN CENTRAL VENOUS CATHETERS, AND MULTIPLE CENTRAL VENOUS CATHETERS), BY PLACEMENT SITE (INTERNAL JUGULAR VEIN, FEMORAL VEIN, AND SUBCLAVIAN VEIN) BY END-USER (HOSPTIALS AND CLINICS, AMBULATORY SURGICAL CENTERS, AND OTHERS) BY GEOGRAPHY IS ESTIMATED TO REGISTER GROWTH AT A REMARKABLE CAGR FORECAST DURING 2024-2030 OWING TO SURGE IN PREVALENCE OF CHRONIC DISEASES AND RISING NUMBER OF BLOOD TRANSFUSIONS.

The global central venous catheters market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.85% during the forecast period from 2024 to 2030 to reach USD 4.04 billion by 2030. The central venous catheters market is slated to witness prosperity owing to factors such as growing prevalence of chronic diseases such as cancer, cardiovascular and kidney diseases among others, increasing sedentary lifestyle, rising number of blood transfusions, and rising number of technological advancements with respect to the products are further expected to result in the appreciable revenue growth in the central venous catheters market during the forecast period (2024-2030).

CENTRAL VENOUS CATHETERS MARKET DYNAMICS:

One of the noteworthy drivers of the central venous catheters market is the rising prevalence of chronic diseases such as cancer, cardiovascular, and kidney diseases among others.

The increasing prevalence of cardiovascular disorders such as heart failure and stroke worldwide due to various factors such as, age, obesity, and others are anticipated to bolster the market. For instance, according to World Health Organization (WHO) 2022, in 2019, cardiovascular diseases (CVDs) was one of the leading cause of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. This indicates the growing need of cardiac surgeries to decrease the mortality rates, further leading to increase in the usage and demand of central venous catheters, positively impacting its market.

The rise in the prevalence of different cancer types where central venous catheters are largely used for providing chemotherapy, and other drugs to patients is going to positively impact the central venous catheters market. As per the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases colon and rectum, 1.41 million cases of prostate, and 1.09 million cases stomach cancer were reported in year 2020.

Moreover, the rising burden of the geriatric patients may increase the prevalence of chronic disorders as age is one of the risk factor for most of the chronic ailments including cancer, cardiovascular, and others. For instance, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). Thus, the increasing number of geriatric patients globally, may increase the demand of the central venous catheters market during the forecast period.

However, rising number of central venous catheter recalls and infections that are associated with central venous catheters market may act as restraining factors to the central venous catheters market growth.

The central venous catheters market reported a short period of restraint in market growth due to the implementation of lockdown as necessary measures to stop the spread of the COVID- 19 infection. The COVID- 19 pandemic resulted in the massive reorganization of the healthcare services and carrying out medical procedures. Many countries segregated medical procedures based on the need for urgent medical care in order to streamline the workflow during the COVID-19 crisis and saw various medical procedures including cardiovascular and other surgeries, chemotherapy sessions, and others considered elective being suspended, therefore leading to decline in the market. However, with the resumption of activities across industries including the healthcare sector, it has been uplifting for the central venous catheters market during the forecast period from 2024-2030.

CENTRAL VENOUS CATHETERS MARKET SEGMENT ANALYSIS:

Central venous catheters market by Product Type (Tunneled Central Venous Catheters and Non-Tunneled Central Venous Catheters), Design (Single Lumen Central Venous Catheters, Double Lumen Central Venous Catheters, and Multiple Central Venous Catheters), Placement Site (Internal Jugular Vein, Femoral Vein, and Subclavian Vein) End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others) Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the product type segment of the central venous catheters market, the tunneled central venous catheters is projected to register a significant growth in revenue in the central venous catheters market during the forecast period (2024-2030).

This can be attributed to the multiple applications and advantages associated with the tunneled central venous catheters. Some of the major advantages of tunneled central venous catheters include its universal applicability as it is functional in nearly 100% of patients, and it can be inserted at multiple sites among others.

Also, these catheters are passed under the skin to a separate exit point which stabilizes them and make them advantageous for the long term therapies such as in case of providing long-term intravenous access for parenteral nutrition, fluid resuscitation, antibiotics, chemotherapy, and hemodialysis. Moreover, patients can continue to receive intravenous therapy upon their discharge from the hospital even after the placement of tunneled catheters for weeks to months.

Tunneled central venous catheters are known to be very secure in the vein, and can be utilized for giving IV therapy in an easier manner, thus reduces discomfort in patients and increases its acceptability.

These catheter also prevents other complications such as burning sensation, and others that happen while getting drugs by other IV methods.

Hence, owing to the various advantages associated with tunneled central venous catheters and its application in multiple indications, the product category is expected to witness a considerable growth eventually contributing to the overall growth of the global central venous catheters market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL CENTRAL VENOUS CATHETERS MARKET:

Among all the regions, North America is expected to lead in revenue generation in the global central venous catheters market. This can be ascribed to the rising prevalence of different cancer types, rise in blood transfusion, and the rising approvals and launch of central venous catheters, particularly in the United States.

One of the key supporting factors for the growth of the North America central venous catheters market is the increasing prevalence of cancers in the United States. As per the figures mentioned by the American Cancer Society 2022, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in the year 2023. Also, according to the data provided by the Centers for Disease Control and Prevention (CDC) 2022, around 1,752,735 new cases of cancer were reported in the US in 2019.

Also, the rising cases of kidney diseases in the region is likely to increase the market growth for central venous catheters. As per the Centers for Disease Control and Prevention (CDC) 2022, around 37 million people have chronic kidney disease (CKD) in the US. The central venous catheters are used for the purpose of haemodialysis (HD) access.

Another important factor responsible for accelerating the US central venous catheters market is the rise in life saving blood transfusion procedures. For instance, according to the Centers for Disease Control and Prevention 2020, there are around 13.2 million blood donors in the United States, which results in a total of 17.2 million transfused blood product units per year.

Therefore, with the presence of large patient pool and major key players of central venous catheters market in the country, the demand for central venous catheters market is going to increase during the forecast period.

CENTRAL VENOUS CATHETERS MARKET KEY PLAYERS:

Some of the key market players operating in the central venous catheters market includes B. Braun Melsungen AG, ZOLL Medical Corporation, VOGT Medical, Insung Medical, Cook Group, Lepu Medical Technology Co., Ltd, Teleflex Incorporated, Poly Medicure Ltd., ICU Medical Inc., Becton, Dickinson and Company, Edwards Lifesciences Corporation, Vygon, Kimal, Medline Industries, LP, Medical Components, Inc., Medtronic, Prunus Medical, Merit Medical Systems, SCW Medicath Ltd, Prodimed, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN CENTRAL VENOUS CATHETERS MARKET:

In March 2022, CorMedix Inc., announced that the resubmission of the New Drug Application (NDA) of DefenCath has been accepted for filing by the U.S. Food and Drug Administration (FDA). DefenCath is indicated for the reduction of catheter-related bloodstream infections (CRBSIs) in patients with renal failure who are receiving chronic hemodialysis via a central venous catheter.

In February 2022, Piccolo Medical received the US FDA clearance of its SmartPICC(TM) System which is used for navigating the positioning of peripherally inserted central catheters.

In March 2020, Access Vascular, Inc. received the US Food and Drug Administration (FDA) clearance for the second generation of its HydroPICCTM peripherally inserted central catheter (PICC).

KEY TAKEAWAYS FROM THE CENTRAL VENOUS CATHETERS MARKET REPORT STUDY

  • Market size analysis for current central venous catheters market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the central venous catheters market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years
  • Key companies dominating the global central venous catheters market.
  • Various opportunities available for the other competitor in the central venous catheters market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current central venous catheters market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for central venous catheters market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS CENTRAL VENOUS CATHETERS MARKET REPORT STUDY

  • Central venous catheters providers
  • Research organizations and consulting companies
  • Central venous catheters-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in central venous catheters.
  • Various end users who want to know more about the central venous catheters market and latest technological developments in the central venous catheters market.

FREQUENTLY ASKED QUESTIONS FOR CENTRAL VENOUS CATHETERS MARKET:

1. What are central venous catheters?

Central venous catheters is basically a long, soft, thin, hollow tube that is placed in a large (central) vein in the neck, upper chest or groin region and is used for the delivery of IV medications over a longer period of time.

2. What is the market for the global central venous catheters?

The global central venous catheters market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.85% during the forecast period from 2024 to 2030 to reach USD 4.04 billion by 2030.

3. What are the drivers for the global central venous catheters market?

The central venous catheters market is slated to witness prosperity owing to factors such as growing prevalence of chronic diseases such as cancer, cardiovascular, and kidney diseases among others, increasing sedentary lifestyle, growing aging population base which is susceptible to the development of multiple diseases, and the growing focus on improving the safety and usability of central venous catheters for end users are further expected to result in the appreciable revenue growth in the central venous catheters market during the forecast period (2024-2030).

4. Who are the key players operating in the global central venous catheters market?

Some of the key market players operating in the central venous catheters market includes B. Braun Melsungen AG, ZOLL Medical Corporation, VOGT Medical, Insung Medical, Cook Group, Lepu Medical Technology Co., Ltd, Teleflex Incorporated, Poly Medicure Ltd., ICU Medical Inc., Becton, Dickinson and Company, Edwards Lifesciences Corporation, Vygon, Kimal, Medline Industries, LP, Medical Components, Inc., Medtronic, Prunus Medical, Merit Medical Systems, SCW Medicath Ltd, Prodimed, and others.

5. Which region has the highest share in the central venous catheters market?

North America is expected to dominate the overall central venous catheters market during the forecast period, 2024 to 2030. This can be ascribed to the presence of large patient pool associated with cancer, kidney, and other diseases, increase in blood transfusion, high consumer awareness regarding new market launches and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1. Central Venous Catheters Market Report Introduction

2. Central Venous Catheters Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Central Venous Catheters Market Key Factors Analysis

  • 4.1 Central Venous Catheters Market Drivers
    • 4.1.1 Increasing prevalence of chronic diseases
    • 4.1.2 Rising burden of the geriatric patients
    • 4.1.3 Rising number of blood transfusions
    • 4.1.4 Rising technological advancements w.r.t the products
  • 4.2 Central Venous Catheters Market Restraints and Challenges
    • 4.2.1 Rising number of central venous catheter recalls
    • 4.2.2 Complications associated with central venous catheters
  • 4.3 Central Venous Catheters Market Opportunities
    • 4.3.1 Rising expenditure on research and development activities around the world for central venous catheters

5. Central Venous Catheters Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Central Venous Catheters Market

7. Central Venous Catheters Market Layout

  • 7.1 By Product Type
    • 7.1.1 Tunneled Central Venous Catheters
    • 7.1.2 Non-Tunneled Central Venous Catheters
  • 7.2 By Design
    • 7.2.1 Manual
    • 7.2.2 Automatic
  • 7.3 By Placement Site
    • 7.3.1 Internal Jugular Vein
    • 7.3.2 Femoral Vein
    • 7.3.3 Subclavian Vein
  • 7.4 By End-user
    • 7.4.1 Hospitals and Clinics
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.1.2 Canada Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.1.3 Mexico Central Venous Catheters Market in USD million (2021-2030)
    • 7.5.2 Europe
      • 7.5.2.1 France Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.2 Germany Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.3 United Kingdom Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.4 Italy Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.5 Spain Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.6 Russia Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.2.7 Rest of Europe Central Venous Catheters Market in USD million (2021-2030)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.3.2 Japan Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.3.3 India Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.3.4 Australia Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.3.5 South Korea Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.3.6 Rest of Asia Pacific Central Venous Catheters Market in USD million (2021-2030)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1. Middle East Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.4.2 Africa Central Venous Catheters Market in USD million (2021-2030)
      • 7.5.4.3 South America Central Venous Catheters Market in USD million (2021-2030)

8. Central Venous Catheters Market Global Company Share Analysis - Key 3-5 Companies

9. Central Venous Catheters Market Company and Product Profiles

  • 9.1 B. Braun Melsungen AG
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2 ZOLL Medical Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3 VOGT Medical
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4 Insung Medical
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5 Cook Group
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6 Lepu Medical Technology Co., Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7 Teleflex Incorporated
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8 Poly Medicure Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9 ICU Medical Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10 Becton, Dickinson and Company
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11 Edwards Lifesciences Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12 Vygon
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13 Kimal
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14 Medline Industries, LP
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15 Medical Components, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16 Medtronic
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17 Prunus Medical
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18 Merit Medical Systems
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19 SCW Medicath Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20 Prodimed
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Central Venous Catheters Market
  • Table 3 Central Venous Catheters Market in Global (2021-2030)
  • Table 4 Central Venous Catheters Market in Global by Product Type (2021-2030)
  • Table 5 Central Venous Catheters Market in Global by Design (2021-2030)
  • Table 6 Central Venous Catheters Market in Global by Placement Site (2021-2030)
  • Table 7 Central Venous Catheters Market in Global by End-user (2021-2030)
  • Table 8 Central Venous Catheters Market in Global by Geography (2021-2030)
  • Table 9 Central Venous Catheters Market in North America (2021-2030)
  • Table 10 Central Venous Catheters Market in North America by Country (2021-2030)
  • Table 11 Central Venous Catheters Market in the US (2021-2030)
  • Table 12 Central Venous Catheters Market in Canada (2021-2030)
  • Table 13 Central Venous Catheters Market in Mexico (2021-2030)
  • Table 14 Central Venous Catheters Market in Europe (2021-2030)
  • Table 15 Central Venous Catheters Market in Europe by Country (2021-2030)
  • Table 16 Central Venous Catheters Market in France (2021-2030)
  • Table 17 Central Venous Catheters Market in Germany (2021-2030)
  • Table 18 Central Venous Catheters Market in the United Kingdom (2021-2030)
  • Table 19 Central Venous Catheters Market in Italy (2021-2030)
  • Table 20 Central Venous Catheters Market in Spain (2021-2030)
  • Table 21 Central Venous Catheters Market in Russia (2021-2030)
  • Table 22 Central Venous Catheters Market in Rest of Europe (2021-2030)
  • Table 23 Central Venous Catheters Market in APAC (2021-2030)
  • Table 24 Central Venous Catheters Market in APAC by Country (2021-2030)
  • Table 25 Central Venous Catheters Market in China (2021-2030)
  • Table 26 Central Venous Catheters Market in Japan (2021-2030)
  • Table 27 Central Venous Catheters Market in India (2021-2030)
  • Table 28 Central Venous Catheters Market in Australia (2021-2030)
  • Table 29 Central Venous Catheters Market in South Korea (2021-2030)
  • Table 30 Central Venous Catheters Market in Rest of APAC (2021-2030)
  • Table 31 Central Venous Catheters Market in Rest of World (2021-2030)
  • Table 32 Central Venous Catheters Market in RoW by Region (2021-2030)
  • Table 33 Central Venous Catheters Market in Middle East (2021-2030)
  • Table 34 Central Venous Catheters Market in Africa (2021-2030)
  • Table 35 Central Venous Catheters Market in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Central Venous Catheters Market
  • Figure 3 Central Venous Catheters Market in Global (2021-2030)
  • Figure 4 Central Venous Catheters Market in Global by Product Type (2021-2030)
  • Figure 5 Central Venous Catheters Market in Global by Design (2021-2030)
  • Figure 6 Central Venous Catheters Market in Global by Placement Site (2021-2030)
  • Figure 7 Central Venous Catheters Market in Global by End-user (2021-2030)
  • Figure 8 Central Venous Catheters Market in Global by Geography (2021-2030)
  • Figure 9 Central Venous Catheters Market in North America (2021-2030)
  • Figure 10 Central Venous Catheters Market in North America by Country (2021-2030)
  • Figure 11 Central Venous Catheters Market in the US (2021-2030)
  • Figure 12 Central Venous Catheters Market in Canada (2021-2030)
  • Figure 13 Central Venous Catheters Market in Mexico (2021-2030)
  • Figure 14 Central Venous Catheters Market in Europe (2021-2030)
  • Figure 15 Central Venous Catheters Market in Europe by Country (2021-2030)
  • Figure 16 Central Venous Catheters Market in France (2021-2030)
  • Figure 17 Central Venous Catheters Market in Germany (2021-2030)
  • Figure 18 Central Venous Catheters Market in the United Kingdom (2021-2030)
  • Figure 19 Central Venous Catheters Market in Italy (2021-2030)
  • Figure 20 Central Venous Catheters Market in Spain (2021-2030)
  • Figure 21 Central Venous Catheters Market in Russia (2021-2030)
  • Figure 22 Central Venous Catheters Market in Rest of Europe (2021-2030)
  • Figure 23 Central Venous Catheters Market in APAC (2021-2030)
  • Figure 24 Central Venous Catheters Market in APAC by Country (2021-2030)
  • Figure 25 Central Venous Catheters Market in China (2021-2030)
  • Figure 26 Central Venous Catheters Market in Japan (2021-2030)
  • Figure 27 Central Venous Catheters Market in India (2021-2030)
  • Figure 28 Central Venous Catheters Market in Australia (2021-2030)
  • Figure 29 Central Venous Catheters Market in South Korea (2021-2030)
  • Figure 30 Central Venous Catheters Market in Rest of APAC (2021-2030)
  • Figure 31 Central Venous Catheters Market in Rest of World (2021-2030)
  • Figure 32 Central Venous Catheters Market in RoW by Region (2021-2030)
  • Figure 33 Central Venous Catheters Market in Middle East (2021-2030)
  • Figure 34 Central Venous Catheters Market in Africa (2021-2030)
  • Figure 35 Central Venous Catheters Market in South America (2021-2030)
  • Figure 36 Market Drivers
  • Figure 37 Market Barriers
  • Figure 38 Marker Opportunities
  • Figure 39 PORTER'S Five Force Analysis